Mitochondrial fatty acid oxidation and acute fatty liver of pregnancy

Seminars in Gastrointestinal Disease

Volumn 13, Issue 1, 2002, Pages 55-66

  Treem, William R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ECLAMPSIA; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; GENE MUTATION; HUMAN; INCIDENCE; LIVER CELL; LIVER MITOCHONDRION; NAUSEA; NEWBORN; NEWBORN CARE; PATHOGENESIS; PERINATAL CARE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; REACTION ANALYSIS; RISK FACTOR; SYMPTOM; VOMITING;

ACUTE DISEASE; FATTY ACIDS; FATTY LIVER; FEMALE; HELLP SYNDROME; HUMANS; LIPID METABOLISM, INBORN ERRORS; LIPID PEROXIDATION; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 0036207973     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases
2. Idiopathic fatty liver of pregnancy: Findings in ten cases
3. Acute fatty liver of pregnancy: An experience in the diagnosis and management of fourteen cases
4. Acute fatty liver of pregnancy: A clinical study of 12 episodes in 11 patients
5. Pregnancy and liver disease
6. Disseminated intravascu]ar coagulation and antithrombin III depression in acute fatty liver pregnancy
7. Radiologic studies in AFLP: A review of the literature and 19 new cases
8. Maternal morbidity and mortality in 442 pregnancy with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)
9. Acute fatty liver of pregnancy: A reassessment based on observations in nine patients
10. Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases
11. Pre-eclampsia: A micro-vesicular fat disease of the liver?
12. Mediumchain and long-chain acyl-CoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome
13. Beta oxidation defects: Biochemistry and clinical
14. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy
15. Increased formation of triglyceride from oleate in perfused livers from pregnant rats
16. 14C] oleate by perfused livers and hepatocytes from female rats
17. Effects of female sex hormones on mitochondria: Possible role in acute fatty liver of pregnancy
18. Carbohydrate metabolism in pregnancy. XVIII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol and individual amino acids in late normal pregnancy
19. The hyperlipidemia of pregnancy in normal and complicated pregnancies
20. Lipid peroxidation in pregnancy: New perspectives on pre- eclampsia
21. Pre-eclampsia: More than pregnancy-induced hypertension
22. Increased lipolytic activity and high ratio of free acids to albumin in sera from women with pre-eclampsia leads to triglyceride accumulation in cultured endothelial cells
23. Reye's syndrome: Salicylates and mitochondrial functions
24. Inhibition by salicylic acid of the activation and thus oxidation of longchain fatty acids: Possible role in the development of Reye's syndrome
25. Reye's syndrome: Current concepts
26. The hepatoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies
27. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic
28. Fatty liver of pregnancy and its relationship to tetracycline therapy
29. Binding of nonsteroidal antiinflammatory drugs to the subunit of the trifunctional protein of long chain fatty acid oxidation
30. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
31. Steatohepatitis: A tale of two "hits"?
32. Increased CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
33. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes
34. The imbalance between thromboxane and prostacyclin in pre-eclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood
35. Free- radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy
36. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
37. The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy
38. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
39. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency
40. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
41. Clinical outcomes in long-chain 3-hyroxyacyl-coenzyme A dehydrogenase deficiency
42. Docosahexaenoic acid and retinal function in children with long-chain 3-hyroxyacyI-CoA dehydrogenase deficiency
43. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women
44. Relationship between unusual hepatic acyl coenzyme A profiles and pathogenesis of Reye syndrome
45. Lipid content in the liver of fatty metamorphosis of pregnancy
46. Serum dicarboxylic acid in patients with Reye syndrome
47. The effect of Reye syndrome serum on isolated chinchilla liver mitochondria
48. Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acid -oxidation intermediates on mitochondrial oxidative phosphorylation
49. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation
50. + + and induces after depolarization in adult ventricular myocytes
51. Inherited long-chain 3-hyroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications
52. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: Molecular characterization of a novel maternal mutant allele
53. Minireview: Liver disease in pregnancy and fetal fatty acid oxidation defects
54. Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy
55. Prevalence of the common mutation for LCHAD deficiency in HELLP syndrome
56. Frequency of the association between maternal liver disease and fetal long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
57. Clinical and biochemical features of trifunctional protein deficiency
58. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy
59. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death
60. Case report: The HELLP syndrome associated with fetal medium-chain acyl-CoA dehydrogenase deficiency
61. Acute fatty liver of pregnancy associated with short chain acyl-coenzyme A dehydrogenase deficiency
62. Heterozygosity for mitochondrial trifunctional protein defect causes hepatic steatosis and elevated liver enzymes in mice
63. Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency
64. Pregnancy outcome and molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations
65. Inborn defects in mitochondrial fatty acid oxidation